Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

CNS disorders

Dec 17, 2020

Mitochondria destruction for Cancer Treatment; Atsena raises USD 55 Million financings; Novartis and Cadent Therapeutics collaboration; Neuron23’s strategy to tackle CNS disorders

Aug 17, 2018

Voltage-Dependent T-Type Calcium Channel Blockers 

May 17, 2018

Business Cocktail

Newsletter/Whitepaper